Simple risk models to predict cardiovascular death in patients with stable coronary artery disease

Ian Ford1, Michele Robertson1, Nicola Greenlaw1

  • 1Robertson Centre for Biostatistics, University of Glasgow, Level 11, Boyd Orr Building, Glasgow G12 8QQ, UK.

Insights

A new risk model using simple clinical factors accurately predicts cardiovascular death in stable coronary artery disease (CAD) patients. This tool aids treatment decisions and resource allocation for better patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Risk Stratification
  • Health Economics

Background:

  • Accurate risk estimation is crucial for motivating patient adherence to treatment.
  • Identifying high-risk individuals with stable coronary artery disease (CAD) can guide the use of potentially expensive, warranted treatments cost-effectively.
  • A simple, accessible risk model for stable CAD patients is needed.

Purpose of the Study:

  • To develop a straightforward risk prediction model for patients with stable coronary artery disease (CAD).
  • The model utilizes readily available clinical risk factors.
  • To improve risk stratification for guiding treatment and resource allocation.

Main Methods:

  • Development of risk models using the CLARIFY registry of stable CAD patients.
  • Initial models incorporated simple clinical variables; subsequent models included left ventricular function, estimated glomerular filtration rate, and hemoglobin.
  • Cox proportional hazards models analyzed cardiovascular death over ~5 years; calibration was assessed in the external CORONOR registry.

Main Results:

  • Models based solely on simple clinical variables demonstrated good discriminatory power (c-statistics of 0.74 in CLARIFY and ≥0.80 in CORONOR).
  • These models showed no lack of calibration in the external dataset.
  • Formulae and integer points-based scores with risk tables were provided.

Conclusions:

  • A preferred model utilizing 10 readily available variables (age, diabetes, smoking, HF symptoms, history of AFib, MI, PAD, stroke, PCI, HF hospitalization) was developed.
  • This model exhibited good discriminatory power and validated well in an external dataset.
  • The developed risk score offers a practical tool for managing stable CAD patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
813
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
545
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
325
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
191
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
313
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
281